424 followers
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States https://t.co/2RvZ4jcBpN https://t.co/tdGJRN8Uhn
Cost of Achieving HbA1c Treatment Targets and Weight Loss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the United States https://t.co/2RvZ4jcBpN https://t.co/tdGJRN8Uhn
New US “cost of control” analysis based on the SUSTAIN 7 RCT, comparing costs of reaching various HbA1c and weight outcomes with semaglutide versus dulaglutide in patients with T2 diabetes inadequately controlled with metformin. https://t.co/Yih8jIS7Sv
Cost of Achieving #HbA1c Treatment Targets and #WeightLoss Responses with Once-Weekly Semaglutide Versus Dulaglutide in the #UnitedStates https://t.co/u0xd02fNeo https://t.co/Zs3JKwyjSn